Percutaneous treatment of liver hydatid disease, clinical experience with 22 patients

الملخص EN

The purpose of this study was to assess the efficacy and validity of the puncture-aspiration –injection and reaspiration (PAIR)and catheterization in the percutaneous treatment of hydatid cyst disease of the liver.

This is aprospective study that had been performed in a major hospital in Basra city, Iraq for the period between April 2010 and May 2014 in which 22 patients with a diagnosis of hydatid cystic disease of liver subjected to a percutaneous treatment using PAIR technique or catheterization method under ultrasonographic guidance and under cover of albandazol or mebandazol before and after intervention .Following aspiration of the cystic fluid ,hypertonic saline 20% was injected into the cystic cavity and re-aspirated .Subsequent follow up and observation was carried out by ultrasonic examination to assess the efficacy and of this approach.Twenty four cyst (72.7%) in this study was GharbiIcyst, 4 patients (18%) had type II and 2 patients only had type III.

The mean reduction in the volume of the cyst after 9-12 months follow up period was 92.6% and 87.5% in catheterization and PAIR method respectively .All patients were in very good condition.

Liver and blood tests were normal after intervention.

Solidification and pseudotumor was seen in 18 patients (81.8 %) and calcification was seen in 12 patients (54.5%).The mean hospitalization time was 3 days.

Percutaneous treatment for selected patients with type I –III Gharbi hydatid liver cyst is effective and safe procedure .It offers complete cure with infrequent complications and short hospitalization.

Surgery however, remains the gold standard treatment for multivesicular, infected and complicated cases of hepatic liver cysts.